Back

Medscape, LLC

  • Hypercholesterolemia

CETP Inhibition and the Evolving LDL-C Playbook: Using Non-Statin LDL-C-Lowering Therapies in Patients With Resistant Hypercholesteremia

The goal of this activity is for learners to be better able to discuss the evolution of non-statin therapies for cardiovascular (CV) risk reduction specifically CETP inhibition and apply emerging evidence to treatment selection and patient communication.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.75 creditsAMA PRA Category 1 Credit™Up to 0.75 creditsNursingUp to 0.75 credits

MOC types

ABIM — Medical KnowledgeUp to 0.75 points

FDA REMS

No

Qualifies for MIPS

No

Faculty 2

All faculty
  • Michelle L O'donoghue, MD

    McGillycuddy-Logue Endowed Chair in Cardiovascular Medicine, Brigham and Women's Hospital

    Cardiovascular Disease

  • Heather M Johnson, MD

    MD; FAHA, FACC, FASPC, Baptist Health South Florida-North Medical Group

    Cardiovascular Disease

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.75 credits
  • MOC · Up to 0.75 points
  • Commercial Support
  • Released
    Feb 19, 2026
  • Last day to claim credit
    Feb 20, 2027 4 months left